Provided by Tiger Trade Technology Pte. Ltd.

Crinetics Pharmaceuticals Inc.

32.92
-1.7100-4.94%
Post-market: 32.920.00000.00%19:59 EDT
Volume:863.20K
Turnover:28.73M
Market Cap:3.47B
PE:-6.42
High:34.80
Open:34.65
Low:32.65
Close:34.63
52wk High:57.99
52wk Low:25.83
Shares:105.44M
Float Shares:96.32M
Volume Ratio:0.76
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1291
EPS(LYR):-4.9500
ROE:-39.17%
ROA:-24.69%
PB:2.71
PE(LYR):-6.65

Loading ...

Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

Major Issues Report

Form 8-K - Current report
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Major Issues Report

Form 8-K - Current report
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2025

Major Issues Report

Form 8-K - Current report
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 26, 2025

Major Issues Report

Form 8-K - Current report
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities